AU6211100A - Improved assays for detecting human immunodeficiency virus infection - Google Patents

Improved assays for detecting human immunodeficiency virus infection

Info

Publication number
AU6211100A
AU6211100A AU62111/00A AU6211100A AU6211100A AU 6211100 A AU6211100 A AU 6211100A AU 62111/00 A AU62111/00 A AU 62111/00A AU 6211100 A AU6211100 A AU 6211100A AU 6211100 A AU6211100 A AU 6211100A
Authority
AU
Australia
Prior art keywords
immunodeficiency virus
virus infection
human immunodeficiency
detecting human
improved assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62111/00A
Inventor
Gregory Cullen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MERLIN BIOMEDICAL AND PHARMACEUTICAL Ltd
Original Assignee
MERLIN BIOMEDICAL AND PHARMACE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MERLIN BIOMEDICAL AND PHARMACE filed Critical MERLIN BIOMEDICAL AND PHARMACE
Publication of AU6211100A publication Critical patent/AU6211100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU62111/00A 1999-07-12 2000-07-12 Improved assays for detecting human immunodeficiency virus infection Abandoned AU6211100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35171799A 1999-07-12 1999-07-12
US09351717 1999-07-12
PCT/US2000/019017 WO2001003721A1 (en) 1999-07-12 2000-07-12 Improved assays for detecting human immunodeficiency virus infection

Publications (1)

Publication Number Publication Date
AU6211100A true AU6211100A (en) 2001-01-30

Family

ID=23382071

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62111/00A Abandoned AU6211100A (en) 1999-07-12 2000-07-12 Improved assays for detecting human immunodeficiency virus infection

Country Status (2)

Country Link
AU (1) AU6211100A (en)
WO (1) WO2001003721A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4895727B2 (en) 2006-08-28 2012-03-14 シスメックス株式会社 Anti-HIV antibody detection reagent, reagent kit, reagent production method, and anti-HIV antibody detection method
CN109324191A (en) * 2008-09-24 2019-02-12 菲鹏生物股份有限公司 The antibody test prize law and its kit of indirectly marked with nanometer granule
CN103389373B (en) * 2012-05-08 2016-04-20 北京勤邦生物技术有限公司 A kind of test paper and application thereof detecting sulfa drugs
JP6553020B2 (en) 2013-03-15 2019-07-31 ジーピービー デット ホールディングス トゥー エルエルシー Automated immunoassay system for performing diagnostic analysis on allergies and autoimmune diseases
EP3278109A4 (en) * 2015-03-30 2018-08-15 Hycor Biomedical, Inc. Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
CN114502957A (en) * 2019-10-14 2022-05-13 深圳迈瑞生物医疗电子股份有限公司 Kit and method for detecting HIV antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659678A (en) * 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4496654A (en) * 1983-04-08 1985-01-29 Quidel Detection of HCG with solid phase support having avidin coating
US4740468A (en) * 1985-02-14 1988-04-26 Syntex (U.S.A.) Inc. Concentrating immunochemical test device and method
US5039604A (en) * 1987-08-21 1991-08-13 Cellular Products, Inc. Test device and method of preparing same, assay kit and method for the simultaneous detection of two HTLV or HIV antibodies

Also Published As

Publication number Publication date
WO2001003721A1 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
AU2002210450A1 (en) Maintaining virus detection software
WO2001064710A8 (en) Sulfated ccr5 peptides for hiv-1 infection
AU1246101A (en) Set for blood processing
AU3440900A (en) Assay system
AU1285300A (en) Hiv vaccine
AUPP967999A0 (en) Viral variants
AU2002255642A1 (en) Sulfated ccr5 peptides for hiv-1 infection
AU3438999A (en) Detection system for human immunodeficiency virus based on nucleic acid amplification
AU6211100A (en) Improved assays for detecting human immunodeficiency virus infection
AU6158700A (en) Vaccine
AU2960000A (en) Detection of human immunodeficiency virus
AU1531801A (en) Novel assay
AU4368800A (en) Assay for hiv-1 infectivity
AU7537400A (en) Assay
AU3862200A (en) Rapid assay for infection in small children
AU4957800A (en) Vaccine against isa virus
AU5848600A (en) Glass-mounted sensor
GB9925432D0 (en) Virus preparation
AU6382000A (en) Genome analysis
AU2002224845A1 (en) Viral expression system
AU5811600A (en) Vaccine
AU3045200A (en) Disposable protection trousers
AU5274099A (en) Hiv vaccine
AUPQ145599A0 (en) Analyte detection
AU1090101A (en) Hiv-1 subtype d peptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase